z-logo
Premium
Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia
Author(s) -
Rajagopalan Bheeshma,
Francis Jane M.,
Cooke Fraser,
Korlipara L. V. Prasad,
Blamire Andrew M.,
Schapira Anthony H.V.,
Madan Jason,
Neubauer Stefan,
Cooper J. Mark
Publication year - 2010
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.22864
Subject(s) - ataxia , medicine , cardiomyopathy , cardiology , age of onset , frataxin , heart disease , disease , cardiac magnetic resonance imaging , cardiac function curve , magnetic resonance imaging , heart failure , radiology , psychiatry , iron binding proteins , transferrin
Friedreich's ataxia (FRDA) has been associated with both cardiac hypertrophy and to a lesser degree dilated cardiomyopathy. We have conducted a cross sectional magnetic resonance imaging (MRI) study of 25 patients with clinically and genetically confirmed FRDA and 24 healthy controls to analyse how disease parameters influence cardiac features in FRDA. MR cine imaging in the long and short axis planes was performed alongside clinical assessments. LV mass was most pronounced in FRDA patients with a larger genetic mutation (GAA1 repeats >600), earlier age of onset (<16years) and a shorter disease duration (<15 years). LV mass decreased with longer disease duration (>15 years), and independent of GAA1 repeat size and age of onset, suggesting cardiac thinning occurred with prolonged disease. Heart function was lower in patients with larger GAA1 repeat number and longer disease duration. Consequently, cardiac hypertrophy was more marked in FRDA patients with a larger GAA1 repeat number and younger age of onset, while prolonged disease duration was associated with lower LV mass and decreased heart function. It is important not only to understand the biochemical basis for these cardiac changes but also allow for these changes when assessing the effect of treatment of FRDA patients. © 2010 Movement Disorder Society

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here